• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Alicia Morgans discusses unmet needs in patients with nmCRPC


"Nonmetastatic castration-resistant prostate cancer remains an incurable disease state," says Alicia Morgans, MD.

In this video, Alicia Morgans, MD, genitourinary medical oncologist, Dana-Farber Cancer Institute, discusses unmet needs in the treatment of patients with nonmetastatic castration-resistant prostate cancer.

Video Transcription

Nonmetastatic castration-resistant prostate cancer (nmCRPC) remains an incurable disease state. And certainly, when we think about where we want to go in the future, we need to think about ways to take incurable disease states, particularly ones with very limited metastatic burden, like a nonmetastatic CRPC patient population, and figure out if there are ways or can be ways that we can cure them of their currently incurable prostate cancer. And as time goes on, I do think the other big push that we have for our patients is to try to figure out if we might be able to limit the use of therapies that decrease testosterone, if that will be possible at some point in time. I think they'll all feel a lot better and certainly will be happy for the major paradigm shift that that would entail.

Transcription has been edited for clarity.

Related Videos
Blurred interior of hospital |  Image Credit: © jakkapan - stock.adobe.com
Laura Bukavina, MD, MPH, answers a question during a Zoom video interview
Image of kidneys | Image Credit: © peterschreiber.media - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
DNA helix | Image Credit: © Siarhei - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.